(Hypertension. 2000;36:103.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From INSERM U460, CHU X. Bichat, Paris France, and INSERM U397 (J.-F.A.), CHU Rangueil, Toulouse, France.
Correspondence to Jean-Baptiste Michel, MD, PhD, INSERM U460, Cardiovascular Remodeling, Faculté de Médecine Xavier Bichat, 16, rue H. Huchard, 75018 Paris, France. E-mail u460{at}bichat.inserm.fr
AbstractIt has previously been
reported that hypertension induced by the chronic blockade of NO
production is characterized by a proinflammatory
phenotype of the arterial wall associated with a
periarterial accumulation of inflammatory cells. In the
present study, the cellular and molecular mechanisms involved in
the luminal and perivascular accumulation of inflammatory cells were
evaluated in the aortas of
NG-nitro-L-arginine methyl ester
(L-NAME)treated rats. Because the medial layer remains intact,
putative markers of the resistance of the vascular wall to cell
migration and to oxidative stress were also explored. For this purpose,
monocyte adhesion, cytokine expression, superoxide anion
production, and nuclear factor-
B (NF-
B) activation were
assessed in the aortas of L-NAMEtreated rats. Expressions of tissue
inhibitor of metalloproteinases-1 (TIMP-1) and heme
oxygenase-1 (HO-1) in the aortic wall were also studied as
possible markers of such resistance. Chronic blockade of NO
production increased ex vivo monocyte adhesion to the
endothelium, increased the production of
superoxide anions, and activated the NF-
B system. In concert
with this modification of the redox state of the vascular wall in
L-NAMEtreated rats, the expression of proinflammatory
cytokines interleukin-6, monocyte chemoattractant protein-1,
and macrophage colonystimulating factor was increased. In
parallel, expressions of both TIMP-1 and HO-1 were increased. All these
changes were prevented by treatment with an
angiotensin-converting enzyme inhibitor
(Zofenopril). Hypertension associated with a proinflammatory
phenotype of the vascular wall induced by blockade of NO
production could be due to an increase in oxidative stress,
which, in turn, activates the NF-
B system and increases gene
expression. In parallel, the arterial wall overexpresses
factors such as TIMP-1 and HO-1, which could participate in the
resistance to cell migration and oxidative stress.
Key Words: Keys words: anions angiotensin-converting enzyme inhibitors cytokines matrix metalloproteinases remodeling
This article has been cited by other articles:
![]() |
H. Hlawaty, A. San Juan, M.-P. Jacob, R. Vranckx, D. Letourneur, and L. J. Feldman Inhibition of MMP-2 gene expression with small interfering RNA in rabbit vascular smooth muscle cells Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3593 - H3601. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-B. Michel, O. Thaunat, X. Houard, O. Meilhac, G. Caligiuri, and A. Nicoletti Topological Determinants and Consequences of Adventitial Responses to Arterial Wall Injury Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1259 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Alam and J. L. Cook How Many Transcription Factors Does It Take to Turn On the Heme Oxygenase-1 Gene? Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 166 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. F. Benter, M. H. M. Yousif, J. T. Anim, C. Cojocel, and D. I. Diz Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H684 - H691. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Fondard, D. Detaint, B. Iung, C. Choqueux, H. Adle-Biassette, M. Jarraya, U. Hvass, J.-P. Couetil, D. Henin, J.-B. Michel, et al. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors Eur. Heart J., July 1, 2005; 26(13): 1333 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sanz-Rosa, M. P. Oubina, E. Cediel, N. de las Heras, O. Vegazo, J. Jimenez, V. Lahera, and V. Cachofeiro Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-{kappa}B/I{kappa}B system Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H111 - H115. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dupuis, F. Soubrier, I. Brocheriou, S. Raoux, M. Haloui, L. Louedec, J.-B. Michel, and S. Nadaud Profiling of Aortic Smooth Muscle Cell Gene Expression in Response to Chronic Inhibition of Nitric Oxide Synthase in Rats Circulation, August 17, 2004; 110(7): 867 - 873. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mazighi, A. Pelle, W. Gonzalez, E. M. Mtairag, M. Philippe, D. Henin, J.-B. Michel, and L. J. Feldman IL-10 inhibits vascular smooth muscle cell activation in vitro and in vivo Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H866 - H871. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Unthank, K. M. Sheridan, and M. C. Dalsing Collateral Growth in the Peripheral Circulation: A Review Vascular and Endovascular Surgery, July 1, 2004; 38(4): 291 - 313. [Abstract] [PDF] |
||||
![]() |
M. G Ferrini, H. H Davila, E. G.A Valente, N. F Gonzalez-Cadavid, and J. Rajfer Aging-related induction of inducible nitric oxide synthase is vasculo-protective to the arterial media Cardiovasc Res, March 1, 2004; 61(4): 796 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Boixel, V. Fontaine, J.-B. Michel, M.-P. Jacob, and S. Hatem Matrix metalloproteinases in atrial fibrillation: Reply J. Am. Coll. Cardiol., January 7, 2004; 43(1): 152 - 153. [Full Text] [PDF] |
||||
![]() |
C. A. Lemarie, B. Esposito, A. Tedgui, and S. Lehoux Pressure-Induced Vascular Activation of Nuclear Factor-{kappa}B: Role in Cell Survival Circ. Res., August 8, 2003; 93(3): 207 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gaertner, D. Lepailleur-Enouf, W. Gonzalez, A. Nicoletti, C. Mandet, M. Philippe, J.-J. Mercadier, and J.-B. Michel Pulmonary endothelium as a site of synthesis and storage of interleukin-6 in experimental congestive heart failure Eur J Heart Fail, August 1, 2003; 5(4): 435 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Fernandez-Real and W. Ricart Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome Endocr. Rev., June 1, 2003; 24(3): 278 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Bouton, B. Richard, P. Rossignol, M. Philippe, M.-C. Guillin, J.-B. Michel, and M. Jandrot-Perrus The Serpin Protease-Nexin 1 Is Present in Rat Aortic Smooth Muscle Cells and Is Upregulated in L-NAME Hypertensive Rats Arterioscler Thromb Vasc Biol, January 13, 2003; 23(1): 142 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Sarang, T. Yoshida, R. Cadet, A. S. Valeras, R. V. Jensen, and S. R. Gullans Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays Physiol Genomics, October 29, 2002; 11(2): 45 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M.A.C. Martens, B. Demeilliers, D. Girardot, C. Daigle, H. H. Dao, D. deBlois, and P. Moreau Vessel-Specific Stimulation of Protein Synthesis by Nitric Oxide Synthase Inhibition: Role of Extracellular Signal-Regulated Kinases 1/2 Hypertension, January 1, 2002; 39(1): 16 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-B. Michel Contrasting Outcomes of Atheroma Evolution: Intimal Accumulation Versus Medial Destruction Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1389 - 1392. [Full Text] [PDF] |
||||
![]() |
L. J. Feldman, M. Mazighi, A. Scheuble, J.-F. Deux, E. De Benedetti, C. Badier-Commander, E. Brambilla, D. Henin, P. G. Steg, and M.-P. Jacob Differential Expression of Matrix Metalloproteinases After Stent Implantation and Balloon Angioplasty in the Hypercholesterolemic Rabbit Circulation, June 26, 2001; 103(25): 3117 - 3122. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tedgui and Z. Mallat Anti-Inflammatory Mechanisms in the Vascular Wall Circ. Res., May 11, 2001; 88(9): 877 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Fernandez-Real, M. Vayreda, C. Richart, C. Gutierrez, M. Broch, J. Vendrell, and W. Ricart Circulating Interleukin 6 Levels, Blood Pressure, and Insulin Sensitivity in Apparently Healthy Men and Women J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1154 - 1159. [Abstract] [Full Text] |
||||
![]() |
E. Mostafa Mtairag, S. Chollet-Martin, M. Oudghiri, N. Laquay, M.-P. Jacob, J.-B. Michel, and L. J. Feldman Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion Cardiovasc Res, March 1, 2001; 49(4): 882 - 890. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |